Vascular Health and Risk Management

Title Publication Date Language Citations
Are we over oxidized? Oxidative stress, cardio-vascular disease, and the future of intervention studies with antioxidants2005/01/01English17
Cardiovascular disease in diabetic nephropathy patients: cell adhesion molecules as potential markers?2005/04/01English16
Valsartan in the treatment of heart attack survivors2006/04/01English16
Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery2006/12/01English16
Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level2006/12/01English16
Optimal lipid modification: the rationale for combination therapy2005/04/01English15
Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy, and coronary calcification2005/04/01English14
Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction2006/04/01English14
Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention2008/01/0114
Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!2008/01/0113
Androgen therapy and atherosclerotic cardiovascular disease2008/01/0113
Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population2008/01/0113
Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target2008/01/0113
Methodological issues in cardiovascular epidemiology: the risk of determining absolute risk through statistical models2006/08/01English11
The genetic basis for altered blood vessel function in disease: large artery stiffening2005/04/01English11
A critical dialogue: communicating with type 2 diabetes patients about cardiovascular risk2005/04/01English11
A review of Perindopril in the reduction of cardiovascular events2006/04/01English10
Evaluation of efficacy and safety of fixed dose lovastatin and niacinER combination in Asian Indian dyslipidemic patients: a multicentric study2006/01/01English10
Barriers to and strategies for effective blood pressure control2005/01/01English10
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure2006/12/01English9
Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy2008/01/019
Screening for popliteal aneurysms should not be a routine part of a community-based aneurysm screening program2006/04/01English9
Insulin detemir in the treatment of type 1 and type 2 diabetes2006/08/01English8
Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy2008/01/018
Nonsteroidal antiinflammatory drugs are associated with increased aortic stiffness2005/01/01English8
Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia2005/01/01English8
Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients2006/12/01English8
Bivalirudin in percutaneous coronary intervention2006/12/01English8
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/ simvastatin combination2006/01/01English8
Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study2005/04/01English8